Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Beta-blockers 'may fight breast cancer'

  • Comment

Women with resistant breast cancer could benefit from the use of beta-blockers that are traditionally prescribed to help those with high blood pressure, new research has indicated.

The spread of breast cancer could be halted with the aid of these drugs, according to a group of experts led by Cancer Research UK scientist Dr Des Powe.

Over the course of a decade, the study revealed that death rates among UK breast cancer patients reduced by 70% among those who took beta-blockers.

Dr Powe said: “We are hypothesising that maybe some of these patients could have their cancer controlled by beta-blockers.”

It is thought that beta-blockers could potentially inhibit a molecular pathway which combines with oestrogen to fuel the growth of breast cancers.

The latest findings follow research published in the Oncotarget journal last year, which suggested that the chances of women dying several years after breast cancer surgery were reduced if they took beta-blockers prior to their operation.

We have a NEW website just for student nurses, with everything from the usual site at a discounted price plus more. Take a look now at and subscribe for just 70p a week.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.